Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Capturing Dynamic Performance in a Cognitive Model: Estimating ACT-R Memory Parameters With the Linear Ballistic Accumulator. | Top Cogn Sci | 2022 | 35531959 | PubTator, text mining | PubMed |
| The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction. | Biomed Res Int | 2022 | 35528155 | PubTator, text mining | PubMed |
| ZFP64::NCOA3 gene fusion defines a novel subset of spindle cell rhabdomyosarcoma. | Genes Chromosomes Cancer | 2022 | 35521817 | PubTator, text mining | PubMed |
| Co-Translational Folding of Multi-Domain Proteins. | Front Mol Biosci | 2022 | 35517860 | PubTator, text mining | PubMed |
| Systematic discovery of mutation-directed neo-protein-protein interactions in cancer. | Cell | 2022 | 35512704 | PubTator, text mining | PubMed |
| Differential Modulation of Nuclear Receptor LRH-1 through Targeting Buried and Surface Regions of the Binding Pocket. | J Med Chem | 2022 | 35503419 | PubTator, text mining | PubMed |
| Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR. | NPJ Breast Cancer | 2022 | 35501333 | PubTator, text mining | PubMed |
| UHMK1 aids colorectal cancer cell proliferation and chemoresistance through augmenting IL-6/STAT3 signaling. | Cell Death Dis | 2022 | 35501324 | PubTator, text mining | PubMed |
| Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies. | J Adv Res | 2022 | 35499045 | PubTator, text mining | PubMed |
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach. | J Med Chem | 2022 | 35482954 | PubTator, text mining | PubMed |
| Hesperidin Ameliorates Dexamethasone-Induced Osteoporosis by Inhibiting p53. | Front Cell Dev Biol | 2022 | 35478958 | PubTator, text mining | PubMed |
| 2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism. | Mol Med | 2022 | 35468719 | PubTator, text mining | PubMed |
| Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care. | Front Cell Dev Biol | 2022 | 35465311 | PubTator, text mining | PubMed |
| SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship. | Appl Bionics Biomech | 2022 | 35465183 | PubTator, text mining | PubMed |
| Deep Learning on Histopathological Images for Colorectal Cancer Diagnosis: A Systematic Review. | Diagnostics (Basel) | 2022 | 35453885 | PubTator, text mining | PubMed |
| Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer. | Technol Cancer Res Treat | 2022 | 35450488 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression. | J Med Virol | 2022 | 35437795 | PubTator, text mining | PubMed |
| Case Report: Molecular Profiling Assists in the Diagnosis and Treatment of Cancer of Unknown Primary. | Front Oncol | 2022 | 35433426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=27